Terms: = Liver cancer AND RBM15, Q96T37, 64783, ENSG00000162775, OTT, OTT1
8 results:
1. Circular RNA cFAM210A, degradable by HBx, inhibits HCC tumorigenesis by suppressing YBX1 transactivation.
Yu J; Li W; Hou GJ; Sun DP; Yang Y; Yuan SX; Dai ZH; Yin HZ; Sun SH; Huang G; Zhou WP; Yang F
Exp Mol Med; 2023 Nov; 55(11):2390-2401. PubMed ID: 37907737
[TBL] [Abstract] [Full Text] [Related]
2. Regulatory mechanism of RNA binding motif protein 15-mediated N
Chen J
Environ Toxicol; 2023 Nov; 38(11):2545-2559. PubMed ID: 37471637
[TBL] [Abstract] [Full Text] [Related]
3. m6A-Related Genes Contribute to Poor Prognosis of Hepatocellular Carcinoma.
Zou Y; Jiang G; Xie Y; Li H
Comput Math Methods Med; 2022; 2022():2427987. PubMed ID: 36339682
[TBL] [Abstract] [Full Text] [Related]
4. Knockdown rbm15 Inhibits Colorectal cancer Cell Proliferation and Metastasis Via N6-Methyladenosine (m6A) Modification of MyD88 mRNA.
Zhang Z; Mei Y; Hou M
Cancer Biother Radiopharm; 2022 Dec; 37(10):976-986. PubMed ID: 34842457
[TBL] [Abstract] [Full Text] [Related]
5. Identification of an m6A-Related Signature as Biomarker for Hepatocellular Carcinoma Prognosis and Correlates with Sorafenib and Anti-PD-1 Immunotherapy Treatment Response.
Jiang H; Ning G; Wang Y; Lv W
Dis Markers; 2021; 2021():5576683. PubMed ID: 34221187
[TBL] [Abstract] [Full Text] [Related]
6. The cancer Genome Atlas (TCGA) based m
Liu J; Sun G; Pan S; Qin M; Ouyang R; Li Z; Huang J
Bioengineered; 2020 Dec; 11(1):759-768. PubMed ID: 32631107
[TBL] [Abstract] [Full Text] [Related]
7. The significance of m6A RNA methylation regulators in predicting the prognosis and clinical course of HBV-related hepatocellular carcinoma.
Fang Q; Chen H
Mol Med; 2020 Jun; 26(1):60. PubMed ID: 32552682
[TBL] [Abstract] [Full Text] [Related]
8. Epitranscriptomics in liver disease: Basic concepts and therapeutic potential.
Zhao Z; Meng J; Su R; Zhang J; Chen J; Ma X; Xia Q
J Hepatol; 2020 Sep; 73(3):664-679. PubMed ID: 32330603
[TBL] [Abstract] [Full Text] [Related]
